Annual Accounts Payable
$1.62 M
-$7.41 M-82.09%
31 December 2023
Summary:
Beam Therapeutics annual accounts payable is currently $1.62 million, with the most recent change of -$7.41 million (-82.09%) on 31 December 2023. During the last 3 years, it has fallen by -$4.70 million (-74.39%). BEAM annual accounts payable is now -82.09% below its all-time high of $9.03 million, reached on 31 December 2022.BEAM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.81 M
-$617.00 K-13.93%
30 September 2024
Summary:
Beam Therapeutics quarterly accounts payable is currently $3.81 million, with the most recent change of -$617.00 thousand (-13.93%) on 30 September 2024. Over the past year, it has increased by +$635.00 thousand (+19.99%). BEAM quarterly accounts payable is now -72.89% below its all-time high of $14.06 million, reached on 31 March 2023.BEAM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.1% | +20.0% |
| 3 y3 years | -74.4% | -47.6% |
| 5 y5 years | -78.0% | -1.2% |
BEAM Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.1% | at low | -72.9% | +135.8% |
| 5 y | 5 years | -82.1% | at low | -72.9% | +135.8% |
| alltime | all time | -82.1% | +122.7% | -72.9% | +135.8% |
Beam Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.81 M(-13.9%) |
| June 2024 | - | $4.43 M(+58.7%) |
| Mar 2024 | - | $2.79 M(+72.5%) |
| Dec 2023 | $1.62 M(-82.1%) | $1.62 M(-49.1%) |
| Sept 2023 | - | $3.18 M(-53.9%) |
| June 2023 | - | $6.89 M(-51.0%) |
| Mar 2023 | - | $14.06 M(+55.8%) |
| Dec 2022 | $9.03 M(+20.8%) | $9.03 M(+28.5%) |
| Sept 2022 | - | $7.02 M(-1.0%) |
| June 2022 | - | $7.09 M(+13.2%) |
| Mar 2022 | - | $6.27 M(-16.2%) |
| Dec 2021 | $7.47 M | $7.47 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $7.28 M(-9.3%) |
| June 2021 | - | $8.03 M(+0.6%) |
| Mar 2021 | - | $7.98 M(+26.4%) |
| Dec 2020 | $6.31 M(-19.5%) | $6.31 M(-3.9%) |
| Sept 2020 | - | $6.57 M(+6.7%) |
| June 2020 | - | $6.15 M(+0.9%) |
| Mar 2020 | - | $6.10 M(-22.2%) |
| Dec 2019 | $7.85 M(+6.7%) | $7.85 M(+103.4%) |
| Sept 2019 | - | $3.86 M(+7.5%) |
| June 2019 | - | $3.59 M(-51.2%) |
| Dec 2018 | $7.35 M(+912.5%) | $7.35 M |
| Dec 2017 | $726.00 K | - |
FAQ
- What is Beam Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Beam Therapeutics?
- What is Beam Therapeutics annual accounts payable year-on-year change?
- What is Beam Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Beam Therapeutics?
- What is Beam Therapeutics quarterly accounts payable year-on-year change?
What is Beam Therapeutics annual accounts payable?
The current annual accounts payable of BEAM is $1.62 M
What is the all time high annual accounts payable for Beam Therapeutics?
Beam Therapeutics all-time high annual accounts payable is $9.03 M
What is Beam Therapeutics annual accounts payable year-on-year change?
Over the past year, BEAM annual accounts payable has changed by -$7.41 M (-82.09%)
What is Beam Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BEAM is $3.81 M
What is the all time high quarterly accounts payable for Beam Therapeutics?
Beam Therapeutics all-time high quarterly accounts payable is $14.06 M
What is Beam Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BEAM quarterly accounts payable has changed by +$635.00 K (+19.99%)